modeRNA Therapeutics has a total of 48 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are MODERNA THERAPEUTICS INC, BELLICUM PHARMACEUTICALS INC and PROYECTO BIOMEDICINA CIMA SL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | WIPO (World Intellectual Property Organization) | 20 | |
#3 | China | 7 | |
#4 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Environmental technology | |
#6 | Measurement | |
#7 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Fermentation | |
#6 | Sugars | |
#7 | Enzymes | |
#8 | Climate change adaptation technologies | |
#9 | Analysing materials | |
#10 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | De Fougerolles Antonin | 37 |
#2 | Bancel Stephane | 29 |
#3 | Schrum Jason P | 27 |
#4 | Elbashir Sayda M | 27 |
#5 | Wood Kristy M | 23 |
#6 | Roy Atanu | 18 |
#7 | Hatala Paul | 18 |
#8 | Guild Justin | 16 |
#9 | Ellsworth Jeff Lynn | 16 |
#10 | Ejebe Kenechi | 15 |
Publication | Filing date | Title |
---|---|---|
WO2013151664A1 | Modified polynucleotides for the production of proteins | |
WO2013106496A1 | Methods and compositions for targeting agents into and across the blood-brain barrier | |
WO2013101690A1 | Modified mrnas encoding cell-penetrating polypeptides | |
WO2013130161A1 | Methods of responding to a biothreat | |
WO2013052523A1 | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof | |
WO2012135805A2 | Delivery and formulation of engineered nucleic acids |